Objective: The aim of this study was to examine the role of isolated rheumatic mitral stenosis (MS) in remodeling of the aorta at various locations.
T he size of the proximal aorta correlates with the diameter of the coronary arteries and has a prognostic role in the occurrence of cardiovascular events. [1] [2] [3] Remodeling of the proximal aorta occurs due to structural changes in the collagen-rich tissue of the aortic wall secondary to chronic shear forces exerted by luminal pressure. Such remodeling is generally observed in chronic hypertension, although other factors, such as inherent weakness of the aortic wall in collagen disease (e.g., Marfan syndrome) can play a significant role in its pathophysiology. [4] The ascending aorta has an important function in vascular hemodynamics and left ventricular (LV) afterload changes, as histological/structural characteristics of the aorta can inversely affect the central pulse pressure and progression of systolic heart failure. [5] Reverse remodeling of the proximal ascending aorta may also occur in conditions where the systolic stroke volume of the LV is diminished. A smaller aorta is reported in patients with systolic heart failure and it carries a relatively poorer prognosis. In other cardiac diseases, obstructive pathology of the mitral valve is associated with reduced systolic stroke of the left heart. [6, 7] Mitral stenosis (MS) is a common consequence of acute rheumatic fever in developing countries; however, the narrowing of the valve and the subsequent hemodynamic changes that develop can take 20 to 40 years to evolve. [8] [9] [10] [11] MS is hemodynamically accompanied by LV under-filling and a smaller stroke volume. [12, 13] It was observed that the size of the ascending aorta in the patient population diagnosed with MS appeared to be smaller, and this study was designed to test this observation. To the best of our knowledge, neither clinical nor pathological studies have drawn attention to any association between aortic diameter and MS. Reverse remodeling of the proximal ascending aorta secondary to MS has not been clearly established. There is little in the literature on this issue at present. This is the first prospective, observational study that aimed to investigate a correlation between the diameter of the proximal aorta measured using transesophageal echocardiography (TEE) and MS. It was hypothesized that the presence of significant MS inversely affects the dimensions of the proximal ascending aorta.
METHODS
This prospective, cross-sectional observational study was undertaken over a period of 12 months at a university-affiliated cardiac imaging clinic. The institutional review board and the ethics committee approved the protocol for its scientific merit and ethical standards. A research team member approached eligible patients and obtained informed, written consent after full disclosure of the study protocol and objectives. Collected clinical information was treated carefully to ensure patient privacy.
Patients aged between 18 and 80 years who were to undergo TEE for any indication between August 1, 2016 and July 31, 2017 were screened for enrollment. The exclusion criteria were patients with Marfan syndrome, bicuspid aortic valve, any degree of aortic stenosis, rheumatic involvement of the aortic valve, non-rheumatic mitral valve pathologies, or prior open-heart surgery. Commissural fusion and diastolic doming of the mitral valve leaflets were considered signs of rheumatic MS. Participants were classified into 2 groups: Group I comprised patients with significant MS [mitral valve area (MVA) ≤1.5 cm 2 ) and Group II was made up of patients without significant MS (MVA >1.5 cm 2 ).
The relevant demographic, anthropometric, and medical history data were recorded. Clinical information, including Framingham's coronary risk factors (hypertension, diabetes mellitus, smoking, hyperlipidemia, and family history of coronary disease), congestive heart failure, atrial fibrillation, cerebrovascular disease, chronic kidney disease, and chronic obstructive pulmonary disease, as well as medication history were also collected.
An experienced cardiologist with special training in echocardiography performed and interpreted all of the TEE examinations. MVA was calculated using a combination of planimetry and the pressure half-time method. Doppler studies were utilized to measure trans-mitral valve gradients. The diameter of the ascending aorta was measured at the levels of the annulus, root, sinotubular junction (STJ), and 5 cm distal to the aortic annulus. The primary endpoint for the current study was the indexed diameter of the aorta measured at 4 levels: a) annulus, b) root, c) STJ, and d) proximal ascending aorta. Indexed values were calculated by dividing the absolute measurements by the body surface area. The body surface area was calculated for every patient using the Mosteller formula as a product of height and weight. [14] In order to conduct the statistical analysis, the distribution of all of the numerical variables was tested using the Kolmogorov-Smirnov test; the data for variables that lacked normal distribution were presented as median [interquartile range (IQR)]. Categorical variables were stated as frequencies with percentages. The comparison of categorical variables between the groups of patients with MS and those without MS was performed using a chi-square analysis or Fischer's exact test, as appropriate. The non-parametric MannWhitney U test was used to compare the difference in the median of numerical variables. Variables affecting the size of the aorta at any level with a p value <0.05 were included in multivariable linear regression models. Gender, age, hypertension, beta-blockers, and MS were identified as the independent variables to be evaluated for their effect on the indexed dimensions of the aorta at each level. A p value <0.05 was considered statistically significant. All of the data were analyzed using IBM SPSS Statistics for Windows, Version 24.0. (IBM Corp., Armonk, NY, USA).
RESULTS
After screening 1080 patients, 179 men and 354 women were eligible to be included in the study. The female/ male ratio in Group I patients with MS was 0.83, dimensions of the aorta at all levels. The aortic annulus was positively related to MVA (r=0.285; p=0.030). Aortic root and STJ measurements were also correlated positively with MVA (r=0.372, p=0.001; r=0.282, p=0.022, respectively). The ascending aorta was also positively correlated with MVA in Pearson's correlation analysis (r=0.422; p<0.001) (Fig. 2 ).
Pearson's correlation coefficient analysis revealed that the peak mitral valve gradient was negatively associated with the aortic root and the ascending aorta (r=-0.217, p=0.023; r=-0.311; p=0.001, respectively). However, there was no significant correlation between peak mitral gradient and the aortic annulus or the STJ (r=-0.106, p=0.357; r=-0.134, p=0.192, respectively) (Fig. 3) .
Four multivariate linear regression models were constructed to assess the independent role of MS with the indexed diameters of the ascending aorta. All variables with a p value <0.05 in univariate analysis in the comparison of the aortic size at all levels, including age, gender, hypertension, and beta blocker use, were selected as independent variables for adjustment in model. MS was found to be correlated with a smaller indexed size of the aortic annulus with a regression coefficient value of 0.541 (p=0.005). Additionally, there was a trend suggesting a smaller aortic root size in patients with MS (p=0.094). Moreover, women had a smaller indexed diameter of the aortic root and the STJ. Similarly, age positively correlated with the dimensions of the aorta above annulus (p<0.001).
DISCUSSION
To the best of our knowledge, the present cross-sectional study is the first to investigate the relationship are less common complications of homozygous familial hypercholesterolemia. [17, 18] Likewise, coarctation of the aorta is frequently reported in patients with mitral valve abnormalities.
[19-21] Rosenquist [22] examined autopsy specimens of 53 patients with a diagnosis of coarctation of the aorta. He noticed that only 9 had a mitral valve of normal size and configuration. In the remaining specimens, the mitral valve demonstrated an abnormal size and/or configuration.
There is also evidence regarding the mitral valve and the aorta in patients who were suffering from hypoplastic left heart syndrome. Sathanandam et al. [23] found in a study of 100 patients that the variants MS-aortic atresia and mitral atresia-aortic atresia were associated with a smaller ascending aorta. In addition, Mori et al. [24] reported that 13 patients required aortic annular enlargement due to underlying hypoplasia of the aortic annulus between isolated MS, MVA, and peak mitral valve gradient and the diameter of the aorta at 4 different levels. Overall, we found MS to be negatively correlated with the annular dimension of the aorta. Moreover, gender, hypertension, and consumption of beta adrenergic blocking agents were demonstrated to be associated with various indexed dimensions of aorta.
Proximal aortic diameter has been shown to be associated with risk of incident coronary heart disease, stroke, cardiovascular events, and all-cause mortality. [1, 3] A smaller aortic root size may occur due to reverse remodeling of the aortic root as a result of disrupted hemodynamics [15, 16] or extensive atheromatous change to the ascending aorta secondary to altered intercellular communications within the aortic wall. Several studies indicated that valvular and/or supravalvular aortic stenosis and a markedly narrowed aortic root was shown that the aortic diameter in hypertensive patients was significantly larger (+0.9 mm) than in normotensive individuals. [31] In another study, Vasan et al. [32] found that the aortic root dimension was directly associated with mean arterial and diastolic blood pressure, and inversely related to pulse and systolic blood pressure. While there was a positive correlation between hypertension and the indexed diameter of the ascending aorta, the dimensions of the aortic annulus were negatively affected by the presence of hypertension. In our patient population, even after adjusting for other confounding variables, hypertension was inversely associated with the indexed dimension of the annulus in multivariate analysis. It should also be noted that myocardial fibrosis is a common sequel of rheumatic fever.
[33] Though we did not include patients with rheumatic involvement of the aortic valve, the extension of rheumatic changes to the aortic-mitral curtain cannot be excluded.
In conclusion, our study demonstrated that rheumatic MS was independently associated with a smaller indexed size of the aortic annulus. However, having rheumatic MS was not independently associated with aortic root, STJ and the proximal ascending aorta.
The present study has limitations. The results may include some potential bias due to the single-center design; thus, it may not be possible to generalize the findings of our study. In addition, this was only a cross-sectional study without a longitudinal follow up. Our control group comprised patients who were undergoing TEE for various indications and were not healthy control subjects. in a study of 71 patients undergoing aortic valve replacement. Nine out of these 13 patients were suffering from concomitant hemodynamically significant MS. This report added to our own anecdotal observations of a lower incidence of aneurysmal dilation of the aorta among the cohort of patients suffering from MS.
Ercan et al. [25] studied 66 patients and described an association between MS and the elastic properties of the aortic wall. Using strain and distensibility as a surrogate marker of elasticity, they found a strong correlation between the distensibility of the aortic wall and MVA (p<0.001; r=0.40). Moreover, aortic wall strain was also associated with MVA (p=0.002; r=0.31), indicating that MS might have contributed to impaired aortic elasticity. These findings are consistent with the results of current study, which indicated a weak but significant correlation between the indexed dimension of the ascending aorta and MVA (Fig. 2) . We also observed an inverse correlation between the peak mitral valve gradient and the indexed size of the aortic dimensions.
Beta blockers have been shown to decrease aortic dilation at the level of the sinus of Valsalva in patients with Marfan syndrome. [26] Likewise, beta blocker therapy has been reported to result in near-normalization of aortic growth velocity in patients with confirmed Marfan syndrome. [27] A decreased stroke volume and the negative inotropic effect of beta blockers are believed to contribute to the beneficial effects. [28] In the current study, significant narrowing of the annulus and the root of the aorta was found to correlate with the presence of MS. It should be considered that the development of elastin lamellae in the media of elastic-type arteries like the aorta appears to be modulated by mechanical factors such as flow. [29] In children suffering from congenital complete heart block, aortic dilatation can develop due long-term exposure to large stroke volumes. [16] After implantation of a pacemaker in these children and normalizing the stroke volume, the size of the ascending aorta regressed. In addition, a decreasing LV end-systolic dimension has been demonstrated to be a long-term adverse outcome of rheumatic MS. [30] On that basis, decreased aortic flow may be responsible for the occurrence of tubular hypoplasia of the aorta. Thus, a possible explanation for the smaller diameters of the aorta is the diminished blood flow to the ascending aorta from the LV.
In our study, hypertension was associated with a larger proximal aortic size in univariate analysis. It
